Liu Y, Zhu J, Wang X, Zhang W, Li Y, Yang Z
J Cancer. 2024; 15(16):5396-5402.
PMID: 39247598
PMC: 11375554.
DOI: 10.7150/jca.98555.
Karayazili M, Celtik U, Ataseven E, Nart D, Ergun O
Pediatr Surg Int. 2024; 40(1):144.
PMID: 38819667
DOI: 10.1007/s00383-024-05721-0.
Kastenberg Z, Short S, Riehle K, Utria A, Lautz T, Ott K
Pediatr Blood Cancer. 2024; 71(6):e30975.
PMID: 38556718
PMC: 11039358.
DOI: 10.1002/pbc.30975.
Espinoza A, Patel K, Shetty P, Whitlock R, Sumazin P, Yu X
Cancer Med. 2023; 12(23):21270-21278.
PMID: 37962078
PMC: 10726870.
DOI: 10.1002/cam4.6705.
Zheng C, Ye S, Liu W, Diao M, Li L
Front Oncol. 2023; 13:1276175.
PMID: 37901310
PMC: 10613067.
DOI: 10.3389/fonc.2023.1276175.
Identification of hepatoblastoma susceptibility loci in the TRMT6 gene from a seven-center case-control study.
Ma L, Zhu J, Zhang J, Zhang W, Li Y, Yang Z
J Cell Mol Med. 2023; 28(1):e18006.
PMID: 37850543
PMC: 10805499.
DOI: 10.1111/jcmm.18006.
A multicenter prospective study on the management of hepatoblastoma in children: a report from the Chinese Children's Cancer Group.
Tang M, Ma X, He X, Pan W, Zhang X, Jiang S
World J Pediatr. 2023; 20(6):590-601.
PMID: 37770810
PMC: 11239770.
DOI: 10.1007/s12519-023-00750-6.
A Clinicopathological Study with Risk-Stratified Staging of Pediatric Hepatoblastoma: A 5-Year Experience from a Tertiary Cancer Center.
Patil Okaly G, Prakash A, Akshatha C, Nargund A, Cherian L, Balu S
Iran J Pathol. 2023; 18(2):165-172.
PMID: 37600579
PMC: 10439754.
DOI: 10.30699/IJP.2023.1972340.3005.
rs4563180 G>C variant reduces hepatoblastoma risk: a case-control study of seven medical centers.
Zeng D, Zhu J, Li J, Liao F, Yang Z, Li Y
Aging (Albany NY). 2023; 15(15):7583-7592.
PMID: 37531210
PMC: 10457066.
DOI: 10.18632/aging.204926.
Preoperative Triple-Phase Three-Dimensional-Multi-Detector Computed Tomography Imaging of the Hepatic Vascular Tree: An Accurate Road Map Prior to Tumor Resection in Hepatoblastoma.
Mitra A, Bhatnagar V, Agarwala S, Gupta A, Jana M, Srinivas M
J Indian Assoc Pediatr Surg. 2023; 28(3):233-241.
PMID: 37389399
PMC: 10305947.
DOI: 10.4103/jiaps.jiaps_113_22.
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictive markers in hepatoblastoma.
Xie T, Hou D, Wang J, Zhao S
Front Pediatr. 2023; 11:904730.
PMID: 37124183
PMC: 10130377.
DOI: 10.3389/fped.2023.904730.
Clinical features and a prognostic nomogram based on the SEER database for hepatoblastoma, hepatocellular carcinoma, and embryonal sarcoma among children and adolescents.
Ge B, Zhuo C, Tang Q, Wu Y
Transl Pediatr. 2023; 12(2):172-184.
PMID: 36891371
PMC: 9986788.
DOI: 10.21037/tp-22-679.
Long-Term Outcome Following Liver Transplantation for Primary Hepatic Tumors-A Single Centre Observational Study over 40 Years.
Leiskau C, Junge N, Mutschler F, Laue T, Ohlendorf J, Richter N
Children (Basel). 2023; 10(2).
PMID: 36832331
PMC: 9954409.
DOI: 10.3390/children10020202.
Surgical resection of pediatric PRETEXT III and IV hepatoblastoma: A retrospective study investigating the need for preoperative chemotherapy.
Wu X, Wang J, Duan Y, Liu Y, Liu Y, Chen X
Front Pediatr. 2022; 10:878095.
PMID: 36533225
PMC: 9751315.
DOI: 10.3389/fped.2022.878095.
Multidisciplinary Management of Pediatric Hepatoblastoma: A 20-Year Single-Center Experience.
Tayfun Kupesiz F, Akinel A, Akbas H, Sivrice C, Tuysuz Kintrup G, Karaguzel G
Turk J Gastroenterol. 2022; 33(12):1069-1078.
PMID: 36262102
PMC: 9797744.
DOI: 10.5152/tjg.2022.21827.
Usefulness of central radiologic review in clinical trials of children with hepatoblastoma.
Miyazaki O, Oguma E, Nishikawa M, Tanami Y, Hosokawa T, Kitami M
Pediatr Radiol. 2022; 53(3):367-377.
PMID: 36255457
DOI: 10.1007/s00247-022-05530-4.
gene polymorphisms increase hepatoblastoma susceptibility in girls.
He S, Zhu J, Xiao Z, Liu J, Zhang J, Li Y
J Cancer. 2022; 13(12):3342-3347.
PMID: 36186903
PMC: 9516011.
DOI: 10.7150/jca.76255.
Advances in the treatment of pediatric solid tumors: A 50-year perspective.
LaQuaglia M, Gerstle J
J Surg Oncol. 2022; 126(5):933-942.
PMID: 36087080
PMC: 9473291.
DOI: 10.1002/jso.27038.
Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma.
Li Q, Demir S, Del Rio-Alvarez A, Maxwell R, Wagner A, Carrillo-Reixach J
Cancers (Basel). 2022; 14(17).
PMID: 36077733
PMC: 9454988.
DOI: 10.3390/cancers14174196.
METTL1 gene polymorphisms synergistically confer hepatoblastoma susceptibility.
Ge L, Zhu J, Liu J, Li L, Zhang J, Cheng J
Discov Oncol. 2022; 13(1):77.
PMID: 35986847
PMC: 9392666.
DOI: 10.1007/s12672-022-00545-7.